Equillium Granted Extension for Nasdaq Compliance

Equillium ( (EQ) ) has shared an announcement.

Equillium, Inc. received a notice from Nasdaq on December 13, 2024, indicating non-compliance with the Minimum Bid Price Requirement as its stock price had been below $1.00 for 30 consecutive business days. Initially given until June 11, 2025, to rectify this, the company was granted an extension until December 8, 2025. Failure to meet the requirement by this date could lead to delisting, though Equillium plans to monitor its stock price and consider options like a reverse stock split to regain compliance. The notification does not immediately affect the trading of its stock, which continues under the symbol ‘EQ.’

The most recent analyst rating on (EQ) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Equillium stock, see the EQ Stock Forecast page.

Spark’s Take on EQ Stock

According to Spark, TipRanks’ AI Analyst, EQ is a Neutral.

Equillium’s stock score is primarily impacted by its financial performance and valuation. The company shows promising revenue growth but struggles with profitability and operational efficiency, leading to a negative P/E ratio. Technical indicators suggest a bearish trend, further weighing on the overall score.

To see Spark’s full report on EQ stock, click here.

More about Equillium

Average Trading Volume: 608,399

Technical Sentiment Signal: Sell

Current Market Cap: $13.79M

For an in-depth examination of EQ stock, go to TipRanks’ Overview page.